Home / Cardiovascular system / Olmesartan Medoxomil and Diuretics
ATC C09DA08 · Agents Acting On The Renin-Angiotensin System
Olmesartan Medoxomil and Diuretics shortage
As of 31 Oct 2026, Olmesartan Medoxomil and Diuretics has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 14 products.
Countries3/5
Products14packs or presentations
Short since31 Aug 20233.2 years ago
Earliest return15 Nov 2026company estimate
No return date11products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | OLMESARTAN E IDROCLOROTIAZIDE ZENTIVA | ZENTIVA ITALIA S.R.L. | 31 Aug 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN E IDROCLOROTIAZIDE ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Sep 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN E IDROCLOROTIAZIDE ZENTIVA | ZENTIVA ITALIA S.R.L. | 30 Nov 2023 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 16 Sep 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 30 Sep 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 9 Dec 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMESARTAN E IDROCLOROTIAZIDE AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 8 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMEGAN announced | DAIICHI SANKYO ITALIA S.P.A. | 30 Nov 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLMEGAN announced | DAIICHI SANKYO ITALIA S.P.A. | 30 Dec 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OLMEGAN announced | DAIICHI SANKYO ITALIA S.P.A. | 30 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | OLMEGAN announced | DAIICHI SANKYO ITALIA S.P.A. | 30 Dec 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| ES | OLMETEC PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | Daiichi Sankyo Espana S.A. | 5 Oct 2026 | 15 Nov 2026 | Not stated |
| BE | Olmetec Plus 40 mg - 25 mg film-coat. tabl. 28 | Daiichi Sankyo Belgium | 13 Aug 2026 | 4 Jan 2027 | Manufacturing problem Delay in production |
| BE | Olmesartan/HCTZ Krka 40 mg - 25 mg film-coat. tabl. 98 | KRKA d.d. Novo mesto | 27 Oct 2026 | 30 Nov 2026 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.